Introduction: Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm characterized by sustained thrombocytosis and an elevated risk of thrombotic and hemorrhagic complications. Standard cytoreductive therapies- such as hydroxyurea, interferons, and anagrelide- are effective in many but are limited by resistance, intolerance, or sub
4 Reached
Pancytopenia, a rare presentation of hyperthyroidism
832 Reached2 Comments
Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
1008 Reached2 Comments
Treatment of Recurrent Adult Medulloblastoma
2602 Reached1 Comments4 Likes
Total Hip Arthroplasty in a Patient with Congenital Insensitivity to Pain
358 Reached4 Comments5 Likes
Chronic Cough in Adolescent
282 Reached1 Comments6 Likes